Chun-Qin Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chun-Qin Zhao has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Shijie Gao
Experimental Centre, Shandong University of Traditional Chinese Medicine, Jinan 250355, P. R. China
2 shared publicationsXiuwei Du
Experimental Centre, Shandong University of Traditional Chinese Medicine, Jinan 250355, P. R. China
2 shared publicationsZhiyi Wang
Experimental Centre, Shandong University of Traditional Chinese Medicine, Jinan 250355, P. R. China
2 shared publications- Cong Chen
Chinese Medicine Institute of Literature and Culture, Shandong University of Traditional Chinese Medicine, Jinan 250355, China
1 shared publication Dan Gao
Innovative Institute of Chinese Medicine and Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, 250355, China
1 shared publicationGao Shijie
Experimental Centre, Shandong University of Traditional Chinese Medicine, Jinan 250355, P. R. China
1 shared publication
Latest Publications
- 31 October 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 294, 118184
Carbon dots loaded liposomes amplified polarity-reversal photoelectrochemical biosensor for the assay of breast cancer exosomal surface proteins
- 31 October 2025
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 294, 118184
Carbon dots loaded liposomes amplified polarity-reversal photoelectrochemical biosensor for the assay of breast cancer exosomal surface proteins
- 4 September 2024
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 21 (10) , 4786-4803
Research Progress on the Strategies for Crossing the Blood–Brain Barrier
Recently, the incidence of brain diseases, such as central nervous system degenerative diseases, brain tumors, and cerebrovascular diseases, has increased. However, the blood-brain barrier (BBB) limits the effective delivery of drugs to brain disease areas. Therefore, the mainstream direction of new drug development for these diseases is to engineer drugs that can better cross the BBB to exert their effects in the brain. This paper reviews the research progress and application of the main trans-BBB drug delivery strategies (receptor/transporter-mediated BBB crossing, focused ultrasound to open the BBB, adenosine agonist reversible opening of the BBB, aromatic resuscitation, transnasal administration, cell-mediated trans-BBB crossing, and viral vector system-mediated brain drug delivery). Meanwhile, the potential applications, advantages, and disadvantages of these strategies for crossing the BBB are analyzed. Finally, the future development prospects of strategies for crossing the BBB are also discussed. These strategies have potential value for treating brain diseases.
- 4 September 2024
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 21 (10) , 4786-4803
Research Progress on the Strategies for Crossing the Blood–Brain Barrier
Recently, the incidence of brain diseases, such as central nervous system degenerative diseases, brain tumors, and cerebrovascular diseases, has increased. However, the blood-brain barrier (BBB) limits the effective delivery of drugs to brain disease areas. Therefore, the mainstream direction of new drug development for these diseases is to engineer drugs that can better cross the BBB to exert their effects in the brain. This paper reviews the research progress and application of the main trans-BBB drug delivery strategies (receptor/transporter-mediated BBB crossing, focused ultrasound to open the BBB, adenosine agonist reversible opening of the BBB, aromatic resuscitation, transnasal administration, cell-mediated trans-BBB crossing, and viral vector system-mediated brain drug delivery). Meanwhile, the potential applications, advantages, and disadvantages of these strategies for crossing the BBB are analyzed. Finally, the future development prospects of strategies for crossing the BBB are also discussed. These strategies have potential value for treating brain diseases.
- 12 February 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (7) , 1662-1692
Self-assembled nanodrug delivery systems for anti-cancer drugs from traditional Chinese medicine
Traditional Chinese medicine (TCM) is a combination of raw herbs and herbal extracts with a plethora of documented beneficial bioactivities, which has unique advantages in anti-tumor therapy, and many of its major bioactive molecules have been identified in recent years due to advances in chemical separation and structural analysis. However, the major chemical classes of plant-derived bioactive compounds frequently possess chemical properties, including poor water solubility, stability, and bioavailability, that limit their therapeutic application. Alternatively, natural small molecules (NSMs) containing these components possess modifiable groups, multiple action sites, hydrophobic side chains, and a rigid skeleton with self-assembly properties that can be exploited to construct self-assembled nanoparticles with therapeutic effects superior to their individual constituents. For instance, the construction of a self-assembled nanodrug delivery system can effectively overcome the strong hydrophobicity and poor in vivo stability of NSMs, thereby greatly improving their bioavailability and enhancing their anti-tumor efficacy. This review summarizes the self-assembly methods, mechanisms, and applications of a variety of NSMs, including terpenoids, flavonoids, alkaloids, polyphenols, and saponins, providing a theoretical basis for the subsequent research on NSMs and the development of SANDDS.
- 12 February 2024
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 12 (7) , 1662-1692
Self-assembled nanodrug delivery systems for anti-cancer drugs from traditional Chinese medicine
Traditional Chinese medicine (TCM) is a combination of raw herbs and herbal extracts with a plethora of documented beneficial bioactivities, which has unique advantages in anti-tumor therapy, and many of its major bioactive molecules have been identified in recent years due to advances in chemical separation and structural analysis. However, the major chemical classes of plant-derived bioactive compounds frequently possess chemical properties, including poor water solubility, stability, and bioavailability, that limit their therapeutic application. Alternatively, natural small molecules (NSMs) containing these components possess modifiable groups, multiple action sites, hydrophobic side chains, and a rigid skeleton with self-assembly properties that can be exploited to construct self-assembled nanoparticles with therapeutic effects superior to their individual constituents. For instance, the construction of a self-assembled nanodrug delivery system can effectively overcome the strong hydrophobicity and poor in vivo stability of NSMs, thereby greatly improving their bioavailability and enhancing their anti-tumor efficacy. This review summarizes the self-assembly methods, mechanisms, and applications of a variety of NSMs, including terpenoids, flavonoids, alkaloids, polyphenols, and saponins, providing a theoretical basis for the subsequent research on NSMs and the development of SANDDS.
- 4 November 2023
- Published by Elsevier in Journal of Chromatography A
- Vol. 1712, 464493
Research progress on nanomaterial-based matrices for matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis
- 4 November 2023
- Published by Elsevier in Journal of Chromatography A
- Vol. 1712, 464493
Research progress on nanomaterial-based matrices for matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis